Denali Therapeutics Inc. (DNLI) Misses Q1 EPS by 8c

Denali Therapeutics Inc. (NASDAQ: DNLI) reported Q1 EPS of ($0.78), $0.08 worse than the analyst estimate of ($0.70).

For earnings history and earnings-related data on Denali Therapeutics Inc. (DNLI) click here.

You May Also Be Interested In

• Casey's General Stores (CASY) Tops Q1 EPS by 69c
• BMO Capital Starts Abercrombie & Fitch (anf) at Outperform
• Activist investor presses Xerox to review financial services arm - Bloomberg